US poised to lose measles elimination status

The United States is expected to lose the measles-elimination status it has held since 2000, as outbreaks have become larger, more frequent, and connected in a pattern of continuing transmission. More than 5,100 cases were reported in 2026, compared with 85 in the year elimination was declared, and at least eight people died from measles that year. The Pan American Health Organization’s review considers whether transmission has continued uninterrupted for at least 12 months, along with outbreak size and surveillance quality. Genetic sequencing may influence its decision by showing whether outbreaks share a virus lineage, though experts caution that a lack of clear genetic links would not erase the evidence of widespread resurgence.

Losing the designation would be a symbolic and international setback, not a penalty: it would signal declining public health and could weaken other countries’ confidence in US vaccine guidance and elimination efforts. Experts also see measles as a warning that other vaccine-preventable diseases may return, with possible implications for pandemic readiness. Political responses are uncertain; a Democratic-controlled Congress might support prevention funding, but the administration could block or withhold resources. The route back is clear: raise vaccination coverage. Measles is exceptionally contagious, while the vaccine is safe, readily available, and about 97% effective after two doses. Brazil, which lost its status in 2019, regained it in 2024, showing that recovery is possible.